Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathwayYongsheng Jia, Brian J. Czerniecki, Shari Pilon‐Thomas et al.|Molecular Therapy|2021Cited by 56
Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the ResponseKrithika N. Kodumudi, Brian J. Czerniecki, Ganesan Ramamoorthi et al.|Frontiers in Immunology|2019Cited by 55
Intratumoral delivery of dendritic cells plus anti-HER2 therapy triggers both robust systemic antitumor immunity and complete regression in HER2 mammary carcinomaGanesan Ramamoorthi, Brian J. Czerniecki, Krithika N. Kodumudi et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 26